Matteo Vergati

Ipilimumab and a poxviral vaccine targeting prostate-specific antigen in metastatic castration-resistant prostate cancer: a phase 1 dose-escalation trial

Ravi A. Madan, Mahsa Mohebtash, Philip M. Arlen et al. · The Lancet Oncology · 2012 · 327 citations · Full text

Medicine, Immunology, Oncology +17

Immunologic and prognostic factors associated with overall survival employing a poxviral-based PSA vaccine in metastatic castrate-resistant prostate cancer

James L. Gulley, Philip M. Arlen, Ravi A. Madan et al. · Cancer Immunology Immunotherapy · 2009 · 298 citations · Full text

Medicine, Immunology, Oncology +17

Systemic administration of GPI 15427, a novel poly(ADP-ribose) polymerase-1 inhibitor, increases the antitumor activity of temozolomide against intracranial melanoma, glioma, lymphoma.

Lucio Tentori, Carlo Leonetti, Marco Scarsella et al. · PubMed · 2003 · 204 citations

Medicine, Oncology, Pharmacology +16

Inhibition of poly(ADP‐ribose) polymerase prevents irinotecan‐induced intestinal damage and enhances irinotecan/temozolomide efficacy against colon carcinoma

Lucio Tentori, Carlo Leonetti, Marco Scarsella et al. · The FASEB Journal · 2006 · 103 citations

Medicine, Oncology, Pharmacology +16

Venous thromboembolism risk prediction in ambulatory cancer patients: Clinical significance of neutrophil/lymphocyte ratio and platelet/lymphocyte ratio

Patrizia Ferroni, Silvia Riondino, Vincenzo Formica et al. · International Journal of Cancer · 2014 · 88 citations · Full text

Medicine, Hematology, Oncology +15